Results 151 to 160 of about 63,989 (248)

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

New England Journal of Medicine, 2017
J. Weitz, A. Lensing, M. Prins, R. Bauersachs, J. Beyer-Westendorf, H. Bounameaux, T. Brighton, A. Cohen, B. Davidson, H. Décousus, M. S. Freitas, G. Holberg, Ajay Kakkar, L. Haskell, B. van Bellen, Á. Pap, S. Berkowitz, P. Verhamme, P. Wells, P. Prandoni   +19 more
semanticscholar   +1 more source

The influence of ABCB1 rs4148738 (C>T) polymorphism on rivaroxaban exposure and bleeding risk in Iraqi patients with non-valvular atrial fibrillation. [PDF]

Qatar Med J
Jalel HK, Hamid MO, Ibadi MH.
europepmc   +1 more source

[Oral Rivaroxaban for the treatment of symptomatic pulmonary embolism].

Revista clínica española (Ed. impresa), 2013
F. García-Bragado Dalmau
semanticscholar   +1 more source

Pharmaceutical Co-Crystal Formulation of Rivaroxaban with Niacinamide: Preparation, Characterization, and In Vitro Release Evaluation. [PDF]

Materials (Basel)
Solomon C, Sarbu I, Anuța V, Ozon EA, Musuc AM, Rusu A, Surdu VA, Chandak A, Gavriloaia RM, Fița AC, Nită DT, Mitu MA.   +11 more
europepmc   +1 more source

Population pharmacokinetic and pharmacodynamic analysis of rivaroxaban in Chinese patients with non-valvular atrial fibrillation

Acta Pharmacologica Sinica, 2022
Xiao-qin Liu, Yu-fei Zhang, H. Ding, Ming-Ming Yan, Z. Jiao, M. Zhong, Chun-Lai Ma   +6 more
semanticscholar   +1 more source

Effects of sleeve gastrectomy on rivaroxaban pharmacokinetics, efficacy, and safety. [PDF]

Front Pharmacol
Alqahtani S, Almutairi A, Aldajani F, Basudan M, Alzahrani A, Alenazi M, Alsarhani E, Alsubaie A, Almaghrabi A, Bamehriz F, Alsubaie H, Algahtani F.   +11 more
europepmc   +1 more source

Rivaroxaban in patients with a recent acute coronary syndrome.

New England Journal of Medicine, 2012
J. Mega, E. Braunwald, S. Wiviott, J. Bassand, Deepak L. Bhatt, C. Bode, P. Burton, Marc Cohen, N. Cook-Bruns, K. Fox, S. Goto, S. Murphy, A. Plotnikov, D. Schneider, Xiang Sun, F. Verheugt, C. Gibson   +16 more
semanticscholar   +1 more source

Relevance and limitations of clinical follow-up in a pharmacokinetic study on direct oral anticoagulants. [PDF]

Front Pharmacol
Terrier J, Gosselin P, Combescure C, Fontana P, Daali Y, Reny JL.   +5 more
europepmc   +1 more source

Medication Adherence and Antithrombotic Therapy Outcomes: Insights From a Post Hoc Analysis of the AFIRE Trial. [PDF]

JACC Asia
Chiba N, Noda T, Nochioka K, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Matsui K, Ogawa H, Yasuda S, AFIRE Investigators.   +14 more
europepmc   +1 more source

Comparative Effectiveness of Oral Anticoagulants and Home Time After Venous Thromboembolism in Frail and Non-Frail Older Adults. [PDF]

Am J Hematol
Park CM, Shi S, Chen X, Parks AL, Kim DH.   +4 more
europepmc   +1 more source